Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma

Modern Pathology

Volumn 9, Issue 10, 1996, Pages 1015-1019

  Tamboli, Pheroze ^a   Amin, Mahul B ^a   Schultz, Daniel S ^a   Linden, Michael D ^a   Kubus, James ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Carcinoma; Immunohistochemistry; Ki 67; MIB 1; Proliferation; Prostate; Prostatic intraepithelial neoplasia

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ARTICLE; CARCINOMA IN SITU; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; CELL DIVISION; DNA, NEOPLASM; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 0029964756     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Amin MB, Ro JY, Ayala AG: Putative precursor lesions of prostatic adenocarcinoma: Fact or fiction? Mod Pathol 6:476, 1993
2. Orteil H: Involuntary changes in prostate and female breast cancer in relation to breast cancer development. Can Med Assoc J 16:237, 1926
3. Bostwick DG: High grade prostatic intraepithelial neoplasia: The most likely precursor of prostate cancer. Cancer 75: 1823, 1995
4. Gerdes J, Lemke H, Baisch H, et al.: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710, 1984
5. Gerdes J, Li L, Schuelter C, et al.: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867, 1991
6. Gerdes J, Becker M, Key G: Immunohistochemical detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues (Letter). J Pathol 168:85, 1992
7. Drago JR, Mostofi FK, Lee F: Introductory remarks and workshop summary: Workshop on prostatic intraepithelial neoplasia, significance and correlation with prostate specific antigen and transrectal ultrasound. Urology 34:2, 1989
8. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS: Architectural patterns of high grade prostatic intraepithelial neoplasia. Hum Pathol 24:298, 1993
9. Shi S, Key M, Kalraa K: Antigen retrieval in formalin-fixed, paraffin-embedded tissues. An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741, 1991
10. McNeal JE, Bostwick DG: Intraductal dysplasia: A premalignant lesion of the prostate. Hum Pathol 17:64, 1986
11. Bostwick DG, Brawer MK: Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 59:788, 1987
12. Troncoso P, Babaian RJ, Ro JY, et al.: Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. Urology 34:52, 1989
13. Epstein JI, Cho KR, Quinn BD: Relationship of severe dysplasia to stage A (incidental) adenocarcinoma of the prostate. Cancer 65:2321, 1990
14. Quinn BD, Cho KR, Epstein JI: Relationship of severe dysplasia to stage B adenocarcinoma of the prostate. Cancer 65:2328, 1990
15. Amin MB, Schultz DS, Zarbo RJ, Kubus J, Shaheen C: Computerized static DNA ploidy analysis of prostatic intraepithelial neoplasia. Arch Pathol Lab Med 117:794, 1993
16. Montironi R, Galluzzi CM, Diamanti L, et al.: Prostatic intraepithelial neoplasia: Expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei. Virchows Arch A Pathol Anat Histopathol 422:185, 1993
17. Sakr WA, Sarkar FH, Sreepathi P, Drozdowicz S, Crissman JD: Measurement of cellular proliferation in human prostate by AGNOR PCNA and SPF. Prostate 22:147, 1993
18. Colombel M, Symmans F, Gil S, et al.: Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone refractory human prostate cancers. Am J Pathol 143:390, 1993
19. Perlman EJ, Epstein JI: Blood group antigen expression in dysplasia and adenocarcinoma of the prostate. Am J Surg Pathol 14:810, 1990
20. Maygarden SJ, Strom S, Ware JL: Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med 116:269, 1992
21. Gerdes J, Schwab U, Lemke H Stein H: Production of a mouse monoclonal antibody reactive with human nuclear antigen associated with cell proliferation. Int J Cancer 31:13, 1983
22. Bonkhoff H, Stein U, Remberger K: The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24:114, 1994
23. Henke RP, Kruger E, Ayhan N, Hubner D, Hammerer P: Numerical chromosomal aberrations in prostate cancer: Correlation with morphology and cell kinetics. Virchows Arch A Pathol Anat Histopathol 422:61, 1993
24. Thompson SJ, Mellon K, Charlton RG, et al.: p53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia. Br J Urol 69:609, 1992
25. Harper ME, Goddard L, Wilson DW, et al.: Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinoma. Prostate 21:75, 1992
26. Drachenberg CB, Papadimitriou JC: Aberrant pattern of lectin binding in low and high grade prostatic intraepithelial neoplasia. Cancer 75:2539, 1995